[HTML][HTML] A systematic review of pregnant women with COVID-19 and their neonates
Abstract Background In December 2019, a novel coronavirus disease (COVID-19) emerged
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …
[HTML][HTML] Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
HM Al-Kuraishy, AI Al-Gareeb… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative virus in the
development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations …
development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations …
Potential clinical benefits of quercetin in the early stage of COVID-19: results of a second, pilot, randomized, controlled and open-label clinical trial
F Di Pierro, S Iqtadar, A Khan… - … journal of general …, 2021 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral …
cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral …
[HTML][HTML] Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its …
An understanding of the pathological inflammatory mechanisms involved in SARS-CoV-2
virus infection is necessary in order to discover new molecular pharmacological targets for …
virus infection is necessary in order to discover new molecular pharmacological targets for …
Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
R Maslennikov, V Ivashkin, E Vasilieva… - European cytokine …, 2021 - Springer
Background Cytokine release syndrome is a serious complication of the new coronavirus
infection (COVID-19). The aim of the study was to assess effectiveness and safety of the IL …
infection (COVID-19). The aim of the study was to assess effectiveness and safety of the IL …
Garcinia kola and garcinoic acid suppress SARS‐CoV‐2 spike glycoprotein S1‐induced hyper‐inflammation in human PBMCs through inhibition of NF‐κB activation
OA Olajide, VU Iwuanyanwu… - Phytotherapy …, 2021 - Wiley Online Library
Symptoms and complications associated with severe SARS‐CoV‐2 infection such as acute
respiratory distress syndrome (ARDS) and organ damage have been linked to SARS‐CoV …
respiratory distress syndrome (ARDS) and organ damage have been linked to SARS‐CoV …
[HTML][HTML] Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной …
СС Бобкова, АА Жуков, ДН Проценко… - … терапии имени АИ …, 2021 - cyberleninka.ru
Актуальность. Новая коронавирусная инфекция (Coronavirus disease 2019, COVID-19)
характеризуется системной гипервоспалительной реакцией с повышением …
характеризуется системной гипервоспалительной реакцией с повышением …
The role of immunomodulatory medications in the treatment of COVID-19
The role of immunomodulatory medications in the treatment of... : Current Opinion in
Rheumatology The role of immunomodulatory medications in the treatment of COVID-19 …
Rheumatology The role of immunomodulatory medications in the treatment of COVID-19 …
[HTML][HTML] Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19
A Saghazadeh, N Rezaei - Emergent Materials, 2021 - Springer
COVID-19 can affect the central nervous system (CNS) indirectly by inflammatory
mechanisms and even directly enter the CNS. Thereby, COVID-19 can evoke a range of …
mechanisms and even directly enter the CNS. Thereby, COVID-19 can evoke a range of …
3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome
E Hunter, C Koutsothanasi, A Wilson, FC Santos… - Biorxiv, 2021 - biorxiv.org
Human infection with the SARS-CoV-2 virus leads to coronavirus disease (COVID-19). A
striking characteristic of COVID-19 infection in humans is the highly variable host response …
striking characteristic of COVID-19 infection in humans is the highly variable host response …